Target intelligence / Profile preview

Ten-eleven translocation 1 (TET1) (TET1)

Target
TET1
Molecular classification
Enzyme, Dioxygenase
01

Overview

Ten-eleven translocation 1 (TET1) is a dioxygenase enzyme encoded by the TET1 gene that catalyzes the sequential oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) in an Fe(II)/α-ketoglutarate-dependent manner, facilitating active DNA demethylation and chromatin regulation.[1][2][5][9] It contains a CXXC domain for binding unmethylated CpG sites and a catalytic domain with cysteine-rich and double-stranded β-helix regions.[1] TET1 recruits histone-modifying complexes to influence gene activation/repression and plays roles in embryonic stem cell maintenance, macrophage differentiation, proinflammatory responses, and processes like liver regeneration and iron homeostasis.[1][2][3] Expressed highly in embryonic stem cells and primordial germ cells, it was first identified as an MLL fusion partner in acute myeloid leukemia.[1][5] Isoforms differ in chromatin affinity and replication site localization.[2]

Other names
Tet methylcytosine dioxygenase 1TET methylcytosine dioxygenase 1
02

Biological functions

DNA demethylationChromatin regulationStem cell maintenanceGene expression regulationInflammation regulationT- and B-cell developmentNeural activityGenomic imprintingDNA repairMeiotic progressionEmbryonic development
03

Disease associations

Cancer (e.g., acute myeloid leukemia, cholangiocarcinoma, intestinal tumorigenesis)InflammationNeurodegenerative disease (e.g., impaired spatial learning and memory)Glioma

Beyond the preview

Go deeper on Ten-eleven translocation 1 (TET1) (TET1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ten-eleven translocation 1 (TET1) (TET1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call